EDMOND DE ROTHSCHILD HOLDING S.A. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 195 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD HOLDING S.A. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$155,400
-19.7%
20,0000.0%0.00%
-25.0%
Q2 2023$193,600
-41.1%
20,000
-33.3%
0.00%
-42.9%
Q1 2023$328,800
+280.6%
30,000
+50.0%
0.01%
+250.0%
Q4 2022$86,400
-42.4%
20,0000.0%0.00%
-50.0%
Q3 2022$150,000
-25.4%
20,0000.0%0.00%
-20.0%
Q2 2022$201,000
-19.0%
20,0000.0%0.01%0.0%
Q1 2022$248,000
-45.7%
20,0000.0%0.01%
-50.0%
Q4 2021$457,000
+3.2%
20,0000.0%0.01%0.0%
Q3 2021$443,000
+581.5%
20,000
+300.0%
0.01%
+400.0%
Q2 2021$65,0005,0000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders